Insulin Glargine Aglr + Octreotide Interaction
Moderateinteraction on record
Description
Somatostatin analog that may increase risk of hypoglycemia. Dosage reductions and increased glucose monitoring may be required.
Source: NLP:insulin glargine-aglr